| Caitlin Schroen, MD | |
|
211 Essex St Ste 204, Hackensack, NJ 07601-3245 | |
| (732) 235-4433 | |
| Not Available |
| Full Name | Caitlin Schroen |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 211 Essex St Ste 204, Hackensack, New Jersey |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205326071 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 25MA11530400 (New Jersey) | Primary |
| Entity Name | Advanced Psychiatric Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760673198 PECOS PAC ID: 8628163284 Enrollment ID: O20070927000853 |
News Archive
Zenobia Therapeutics, Inc. the leader in fragment-based lead discovery for CNS diseases, announced today a research collaboration with H. Lundbeck A/S utilizing Zenobia's expertise in protein expression and x-ray crystallography for the Parkinson's disease target, LRRK2. Under the agreement, Zenobia will continue to use its capabilities in fragment-based lead discovery (FBLD) to advance its internal LRRK2 drug discovery program independently of Lundbeck.
The Margaret A. Cargill Foundation provides the Institute of Tropical Medicine in Antwerp with a 3-year project grant worth nearly 5 million dollars to develop a new model to fight sleeping sickness.
Health researchers at the Christchurch School of Medicine and Health Sciences, Otago University, have found evidence of new risk factors associated with a debilitating illness called Inflammatory Bowel Disease (IBD).
Atacama Labs Oy has developed an innovative oral drug delivery technology (called 'pneumatic dry granulation' or 'PDG Technology(TM)'). The technology is aimed to replace existing solid dosage form development and manufacturing methods (like wet granulation or standard roller compaction) and will help both NCE galenic developers and life cycle managers to overcome development or differentiation issues.
› Verified 2 days ago
| Entity Name | Mccd New Jersey Psychiatry Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023729530 PECOS PAC ID: 8921452350 Enrollment ID: O20231003003019 |
News Archive
Zenobia Therapeutics, Inc. the leader in fragment-based lead discovery for CNS diseases, announced today a research collaboration with H. Lundbeck A/S utilizing Zenobia's expertise in protein expression and x-ray crystallography for the Parkinson's disease target, LRRK2. Under the agreement, Zenobia will continue to use its capabilities in fragment-based lead discovery (FBLD) to advance its internal LRRK2 drug discovery program independently of Lundbeck.
The Margaret A. Cargill Foundation provides the Institute of Tropical Medicine in Antwerp with a 3-year project grant worth nearly 5 million dollars to develop a new model to fight sleeping sickness.
Health researchers at the Christchurch School of Medicine and Health Sciences, Otago University, have found evidence of new risk factors associated with a debilitating illness called Inflammatory Bowel Disease (IBD).
Atacama Labs Oy has developed an innovative oral drug delivery technology (called 'pneumatic dry granulation' or 'PDG Technology(TM)'). The technology is aimed to replace existing solid dosage form development and manufacturing methods (like wet granulation or standard roller compaction) and will help both NCE galenic developers and life cycle managers to overcome development or differentiation issues.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Caitlin Schroen, MD 211 Essex St Ste 204, Hackensack, NJ 07601-3245 Ph: () - | Caitlin Schroen, MD 211 Essex St Ste 204, Hackensack, NJ 07601-3245 Ph: (732) 235-4433 |
News Archive
Zenobia Therapeutics, Inc. the leader in fragment-based lead discovery for CNS diseases, announced today a research collaboration with H. Lundbeck A/S utilizing Zenobia's expertise in protein expression and x-ray crystallography for the Parkinson's disease target, LRRK2. Under the agreement, Zenobia will continue to use its capabilities in fragment-based lead discovery (FBLD) to advance its internal LRRK2 drug discovery program independently of Lundbeck.
The Margaret A. Cargill Foundation provides the Institute of Tropical Medicine in Antwerp with a 3-year project grant worth nearly 5 million dollars to develop a new model to fight sleeping sickness.
Health researchers at the Christchurch School of Medicine and Health Sciences, Otago University, have found evidence of new risk factors associated with a debilitating illness called Inflammatory Bowel Disease (IBD).
Atacama Labs Oy has developed an innovative oral drug delivery technology (called 'pneumatic dry granulation' or 'PDG Technology(TM)'). The technology is aimed to replace existing solid dosage form development and manufacturing methods (like wet granulation or standard roller compaction) and will help both NCE galenic developers and life cycle managers to overcome development or differentiation issues.
› Verified 2 days ago
David Steinberg, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 940 Main St, Hackensack, NJ 07601 Phone: 201-487-2273 | |
Dr. Shani Stein, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 60 Second St, 1st Floor Hackensack University Medical Center, Hackensack, NJ 07601 Phone: 201-996-3440 Fax: 201-996-5995 | |
Dr. Harshasu Barot, D.O. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 30 Prospect Ave, Hackensack, NJ 07601 Phone: 844-464-9355 | |
Alberto Mario Goldwaser, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 24 Bergen St, Hackensack, NJ 07601 Phone: 201-342-3500 Fax: 201-342-1900 | |
Dr. Samuel Singer, M.D Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 92 2nd St, Hackensack, NJ 07601 Phone: 551-996-5266 Fax: 551-996-0589 | |
Dr. Kaitlin Johanna Reilly-kit, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 360 Essex St., Suite 303, Hackensack, NJ 07601 Phone: 551-996-8100 | |
Dr. Rolando Sousa, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 20 Prospect Ave, Suite 905, Hackensack, NJ 07601 Phone: 973-222-4653 Fax: 646-304-3194 |